Summary
The effects of single doses of CL284,846 (20 mg), lorazepam (2 mg) and placebo on psychomotor performance, memory function and subjective feelings were assessed in 12 normal, healthy male volunteers. Each subject received each treatment in balanced order and a minimum of 6 days was left between treatments.
The subjects performance on a comprehensive battery of tests of psychomotor performance, memory function and subjective ratings was assessed pre-treatment and at 1, 3 and 5 h post-treatment.
In general, the effects of CL284,846 on memory were similar to those of lorazepam at 1 h post-treatment but, recovery was rapid with CL284,846. Impairments induced by lorazepam persisted throughout the post-drug testing sessions.
This pattern of effects was repeated across most of the variables tested. However, at 1 h, CL284,846 produced less marked psychomotor impairment than lorazepam.
The results of this study suggest that CL284,846 is a safe, rapid acting and effective sedative with some clear advantages over lorazepam with respect to unwanted cognitive and psychomotor impairments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abel MS, Day I (1990) Screening for a new anxiolytic. Correlations of TBPS binding in vitro and degree of sedative-hypnotic effects in vivo. American Cynamid CNS Department Research Seminars, Pearl River, New York
Allen D, Baylav A, Lader M (1988) A comparative study of the interaction of alcohol with alpidem, lorazepam and placebo in normal subjects. Int Clin Psychpharmacol 3: 327–341
Allen D, Curran HV, Lader M (1991) The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. Eur J Clin Pharmacol 40: 355–362
Allen D, Lader M (1992) The interactions of ethanol with single and repeated doses of suriclone and diazepam on physiological and psychomotor functions in normal subjects. Eur J Clin Pharmacol 42: 499–505
Baddeley AD (1968) A 3 min reasoning test based on grammatical transformation. Psychosom Sci 10: 341–342
Beer B, Ieni JR, Rose J, Mant T, Gaudreult J, Stern W (1993) A placebo controlled safety, pharmacokinetic and psychometric evaluation in normal volunteers of single, escalating doses of CL284,846, a non-benzodiazepine hypnotic. J Clin Pharmacol (in press)
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. J Med Psychol 47: 211–218
Costa E (1989) Allosteric modulatory centers of transmitter amino acid receptors. Neuropsychopharmacology 2: 167–174
Curran HV (1986) Tranquillizing memories: a review of the effects of the effects of benzodiazepines on human memory. Biol Psychol 23: 179–213
Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105: 1–8
Curran HV, Birch B (1991 a) Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology 103: 519–523
Curran HV, Schifano F, Lader M (1991 b) Models of memory dysfunction? a comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology 103: 83–90
Curran HV, Schiwy W, Lader M (1987) Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives. Psychopharmacology 92: 358–364
Davis JM (1985) Minor tranquillizers, sedatives and hypnotics. In: Kaplan HI, Sadock BJ (eds) Comprehensive Textbook of Psychiatry. Williams and Wilkins, Baltimore, pp 1537–1553
Frewer LJ, Lader M (1991) The effects of caffeine on two computerised tests of attention and vigilance. Human Psychopharmacology 6: 119–128
Ghoneim MM, Mewaldt SP (1990) Benzodiazepines and memory: a review. Anaesthesiology 72: 926–938
Johnson C, Chernik DA (1982) Sedative-hypnotics and human performance. Psychopharmacology 76: 101–113
Harvey SC (1985) Hypnotics and sedatives. In: Goodman A, Gilman LD (eds) The pharmacological basis of therapeutics. Macmillan, New York, 339–371
Kales A, Soldatos CR, Bixler EO, Kales JD (1983) Rebound insomnia and rebound anxiety: a review. Pharmacology 26: 121–137
Mendelson WB (1987) Medications in the treatment of sleep disorders. In: Metzler HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, 1305–1311
Ramanjaneyulu R, Ticku MK (1984) Binding characteristics and interactions of depressant drugs with [35S]-butylbicyclophosphorothionate, a ligand that binds to the picrotoxin site. J Neurochem 42: 221–229
Shepherd RN, Metzler J (1971) Mental rotation of three- dimensional objects. Science 171: 701–703
Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York
Wilson B, Cockburn J, Baddeley A (1985) The Revermead behavioral memory test. Thames Valley Test Company, Reading
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allen, D., Curran, H.V. & Lader, M. The effects of single doses of CL 284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. Eur J Clin Pharmacol 45, 313–320 (1993). https://doi.org/10.1007/BF00265947
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265947